WO2024075134A1 - Dispersion moléculaire supercritique (solution vraie) de bioactif lipophile dans une matrice lipidique et procédé correspondant - Google Patents
Dispersion moléculaire supercritique (solution vraie) de bioactif lipophile dans une matrice lipidique et procédé correspondant Download PDFInfo
- Publication number
- WO2024075134A1 WO2024075134A1 PCT/IN2023/050899 IN2023050899W WO2024075134A1 WO 2024075134 A1 WO2024075134 A1 WO 2024075134A1 IN 2023050899 W IN2023050899 W IN 2023050899W WO 2024075134 A1 WO2024075134 A1 WO 2024075134A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- oil
- scf
- dispersion
- bioactive
- lipophilic
- Prior art date
Links
- 230000000975 bioactive effect Effects 0.000 title claims abstract description 124
- 239000006185 dispersion Substances 0.000 title claims abstract description 119
- 238000000034 method Methods 0.000 title claims abstract description 110
- 239000011159 matrix material Substances 0.000 title claims abstract description 48
- 150000002632 lipids Chemical class 0.000 title claims description 63
- 229910002092 carbon dioxide Inorganic materials 0.000 claims abstract description 121
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims abstract description 78
- 239000001569 carbon dioxide Substances 0.000 claims abstract description 24
- 238000000605 extraction Methods 0.000 claims description 65
- 239000003921 oil Substances 0.000 claims description 65
- 235000019198 oils Nutrition 0.000 claims description 64
- 235000021466 carotenoid Nutrition 0.000 claims description 56
- 150000001747 carotenoids Chemical class 0.000 claims description 56
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 claims description 52
- 239000002245 particle Substances 0.000 claims description 51
- 230000008569 process Effects 0.000 claims description 48
- 239000000463 material Substances 0.000 claims description 32
- 239000003381 stabilizer Substances 0.000 claims description 26
- 241000196324 Embryophyta Species 0.000 claims description 21
- 235000013305 food Nutrition 0.000 claims description 21
- 239000002904 solvent Substances 0.000 claims description 21
- 239000000203 mixture Substances 0.000 claims description 20
- 238000002156 mixing Methods 0.000 claims description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 18
- 239000002600 sunflower oil Substances 0.000 claims description 17
- 235000019486 Sunflower oil Nutrition 0.000 claims description 16
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 claims description 16
- 150000003904 phospholipids Chemical class 0.000 claims description 11
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 claims description 10
- 239000000654 additive Substances 0.000 claims description 10
- 235000013793 astaxanthin Nutrition 0.000 claims description 10
- 239000001168 astaxanthin Substances 0.000 claims description 10
- 229940022405 astaxanthin Drugs 0.000 claims description 10
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 claims description 10
- 229930003799 tocopherol Natural products 0.000 claims description 9
- 239000011732 tocopherol Substances 0.000 claims description 9
- 239000003963 antioxidant agent Substances 0.000 claims description 8
- 235000006708 antioxidants Nutrition 0.000 claims description 8
- 235000012754 curcumin Nutrition 0.000 claims description 8
- 239000004148 curcumin Substances 0.000 claims description 8
- 229940109262 curcumin Drugs 0.000 claims description 8
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 8
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 claims description 8
- 235000012424 soybean oil Nutrition 0.000 claims description 8
- 239000003549 soybean oil Substances 0.000 claims description 8
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims description 8
- 238000004513 sizing Methods 0.000 claims description 6
- 235000010384 tocopherol Nutrition 0.000 claims description 6
- 229960001295 tocopherol Drugs 0.000 claims description 6
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 claims description 5
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 claims description 5
- 235000019483 Peanut oil Nutrition 0.000 claims description 5
- 235000005687 corn oil Nutrition 0.000 claims description 5
- 239000002285 corn oil Substances 0.000 claims description 5
- 235000020660 omega-3 fatty acid Nutrition 0.000 claims description 5
- 229940012843 omega-3 fatty acid Drugs 0.000 claims description 5
- 239000006014 omega-3 oil Substances 0.000 claims description 5
- 239000000312 peanut oil Substances 0.000 claims description 5
- 239000000843 powder Substances 0.000 claims description 5
- 239000008513 turmeric extract Substances 0.000 claims description 5
- 229940052016 turmeric extract Drugs 0.000 claims description 5
- 235000020240 turmeric extract Nutrition 0.000 claims description 5
- GJJVAFUKOBZPCB-ZGRPYONQSA-N (r)-3,4-dihydro-2-methyl-2-(4,8,12-trimethyl-3,7,11-tridecatrienyl)-2h-1-benzopyran-6-ol Chemical class OC1=CC=C2OC(CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)(C)CCC2=C1 GJJVAFUKOBZPCB-ZGRPYONQSA-N 0.000 claims description 4
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 4
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 4
- 229930003448 Vitamin K Natural products 0.000 claims description 4
- 244000273928 Zingiber officinale Species 0.000 claims description 4
- 235000006886 Zingiber officinale Nutrition 0.000 claims description 4
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 4
- 239000000828 canola oil Substances 0.000 claims description 4
- 235000019519 canola oil Nutrition 0.000 claims description 4
- 230000002708 enhancing effect Effects 0.000 claims description 4
- 235000008397 ginger Nutrition 0.000 claims description 4
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 claims description 4
- 229930003802 tocotrienol Natural products 0.000 claims description 4
- 239000011731 tocotrienol Substances 0.000 claims description 4
- 235000019148 tocotrienols Nutrition 0.000 claims description 4
- 229940068778 tocotrienols Drugs 0.000 claims description 4
- 235000019155 vitamin A Nutrition 0.000 claims description 4
- 239000011719 vitamin A Substances 0.000 claims description 4
- 235000019168 vitamin K Nutrition 0.000 claims description 4
- 239000011712 vitamin K Substances 0.000 claims description 4
- 150000003721 vitamin K derivatives Chemical class 0.000 claims description 4
- 229940045997 vitamin a Drugs 0.000 claims description 4
- 229940046010 vitamin k Drugs 0.000 claims description 4
- 229920002565 Polyethylene Glycol 400 Polymers 0.000 claims description 3
- 235000019485 Safflower oil Nutrition 0.000 claims description 3
- 235000010385 ascorbyl palmitate Nutrition 0.000 claims description 3
- 239000004359 castor oil Substances 0.000 claims description 3
- 235000019438 castor oil Nutrition 0.000 claims description 3
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims description 3
- 235000020748 rosemary extract Nutrition 0.000 claims description 3
- 229940092258 rosemary extract Drugs 0.000 claims description 3
- 239000001233 rosmarinus officinalis l. extract Substances 0.000 claims description 3
- 235000005713 safflower oil Nutrition 0.000 claims description 3
- 239000003813 safflower oil Substances 0.000 claims description 3
- 230000000087 stabilizing effect Effects 0.000 claims description 3
- 125000002640 tocopherol group Chemical class 0.000 claims description 3
- 235000019149 tocopherols Nutrition 0.000 claims description 3
- 238000009827 uniform distribution Methods 0.000 claims description 3
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 claims description 2
- 235000000072 L-ascorbyl-6-palmitate Nutrition 0.000 claims description 2
- 235000017471 coenzyme Q10 Nutrition 0.000 claims description 2
- 229940110767 coenzyme Q10 Drugs 0.000 claims description 2
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 claims description 2
- 239000012530 fluid Substances 0.000 abstract description 18
- 210000002784 stomach Anatomy 0.000 abstract description 4
- 230000037406 food intake Effects 0.000 abstract description 3
- 239000007908 nanoemulsion Substances 0.000 abstract description 3
- 238000002425 crystallisation Methods 0.000 abstract description 2
- 230000008025 crystallization Effects 0.000 abstract description 2
- 239000000284 extract Substances 0.000 description 38
- 238000010521 absorption reaction Methods 0.000 description 31
- 239000004006 olive oil Substances 0.000 description 31
- 239000000243 solution Substances 0.000 description 31
- 235000008390 olive oil Nutrition 0.000 description 30
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 26
- 235000005881 Calendula officinalis Nutrition 0.000 description 25
- 240000000785 Tagetes erecta Species 0.000 description 25
- 229960005375 lutein Drugs 0.000 description 25
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 25
- 235000012680 lutein Nutrition 0.000 description 21
- 239000001656 lutein Substances 0.000 description 21
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 21
- 235000015112 vegetable and seed oil Nutrition 0.000 description 21
- 239000008158 vegetable oil Substances 0.000 description 21
- 235000015097 nutrients Nutrition 0.000 description 19
- 235000021436 nutraceutical agent Nutrition 0.000 description 17
- 230000015572 biosynthetic process Effects 0.000 description 16
- 239000007788 liquid Substances 0.000 description 16
- 238000002360 preparation method Methods 0.000 description 16
- 230000001926 lymphatic effect Effects 0.000 description 15
- 239000002417 nutraceutical Substances 0.000 description 15
- 239000004094 surface-active agent Substances 0.000 description 15
- 229940079593 drug Drugs 0.000 description 13
- 239000003814 drug Substances 0.000 description 13
- 239000002540 palm oil Substances 0.000 description 12
- 235000019482 Palm oil Nutrition 0.000 description 11
- 235000012054 meals Nutrition 0.000 description 11
- 239000000693 micelle Substances 0.000 description 11
- 239000000126 substance Substances 0.000 description 11
- 238000000265 homogenisation Methods 0.000 description 10
- 230000000968 intestinal effect Effects 0.000 description 10
- 239000012053 oil suspension Substances 0.000 description 10
- 230000032258 transport Effects 0.000 description 10
- 150000001875 compounds Chemical class 0.000 description 9
- 238000005516 engineering process Methods 0.000 description 9
- 210000004185 liver Anatomy 0.000 description 9
- 239000012071 phase Substances 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- 239000003960 organic solvent Substances 0.000 description 8
- 241000208818 Helianthus Species 0.000 description 7
- 239000012296 anti-solvent Substances 0.000 description 7
- 238000007796 conventional method Methods 0.000 description 7
- 238000013461 design Methods 0.000 description 7
- 238000009472 formulation Methods 0.000 description 7
- 230000001965 increasing effect Effects 0.000 description 7
- 210000002381 plasma Anatomy 0.000 description 7
- 239000013078 crystal Substances 0.000 description 6
- 235000005911 diet Nutrition 0.000 description 6
- 239000002105 nanoparticle Substances 0.000 description 6
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 6
- 235000008210 xanthophylls Nutrition 0.000 description 6
- 241001133760 Acoelorraphe Species 0.000 description 5
- 235000003222 Helianthus annuus Nutrition 0.000 description 5
- 239000004964 aerogel Substances 0.000 description 5
- 239000003240 coconut oil Substances 0.000 description 5
- 235000019864 coconut oil Nutrition 0.000 description 5
- 238000009826 distribution Methods 0.000 description 5
- 150000004665 fatty acids Chemical class 0.000 description 5
- 238000010579 first pass effect Methods 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 238000003801 milling Methods 0.000 description 5
- 238000001556 precipitation Methods 0.000 description 5
- 238000012546 transfer Methods 0.000 description 5
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 4
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 4
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 240000007817 Olea europaea Species 0.000 description 4
- 239000005642 Oleic acid Substances 0.000 description 4
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 4
- 230000029087 digestion Effects 0.000 description 4
- 238000004090 dissolution Methods 0.000 description 4
- 239000003925 fat Substances 0.000 description 4
- 235000019197 fats Nutrition 0.000 description 4
- 239000000194 fatty acid Substances 0.000 description 4
- 239000010419 fine particle Substances 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 238000011835 investigation Methods 0.000 description 4
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 239000004533 oil dispersion Substances 0.000 description 4
- 239000008601 oleoresin Substances 0.000 description 4
- 230000036470 plasma concentration Effects 0.000 description 4
- 229920001223 polyethylene glycol Polymers 0.000 description 4
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 4
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 4
- 229920000053 polysorbate 80 Polymers 0.000 description 4
- 229940068968 polysorbate 80 Drugs 0.000 description 4
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 238000002798 spectrophotometry method Methods 0.000 description 4
- -1 sunflower lecithin Chemical class 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 235000013311 vegetables Nutrition 0.000 description 4
- 239000001993 wax Substances 0.000 description 4
- 108010004103 Chylomicrons Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 230000001166 anti-perspirative effect Effects 0.000 description 3
- 239000003213 antiperspirant Substances 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000015556 catabolic process Effects 0.000 description 3
- 238000006731 degradation reaction Methods 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 230000000378 dietary effect Effects 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 238000009792 diffusion process Methods 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 230000031891 intestinal absorption Effects 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 210000004324 lymphatic system Anatomy 0.000 description 3
- 230000037361 pathway Effects 0.000 description 3
- 210000003240 portal vein Anatomy 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 210000000813 small intestine Anatomy 0.000 description 3
- 238000002466 solution-enhanced dispersion by supercritical fluid Methods 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 238000005507 spraying Methods 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 235000003276 Apios tuberosa Nutrition 0.000 description 2
- 244000105624 Arachis hypogaea Species 0.000 description 2
- 235000010777 Arachis hypogaea Nutrition 0.000 description 2
- 235000010744 Arachis villosulicarpa Nutrition 0.000 description 2
- 239000002028 Biomass Substances 0.000 description 2
- 235000014698 Brassica juncea var multisecta Nutrition 0.000 description 2
- 235000006008 Brassica napus var napus Nutrition 0.000 description 2
- 240000000385 Brassica napus var. napus Species 0.000 description 2
- 235000006618 Brassica rapa subsp oleifera Nutrition 0.000 description 2
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 2
- 244000060011 Cocos nucifera Species 0.000 description 2
- 235000013162 Cocos nucifera Nutrition 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 2
- 108090001030 Lipoproteins Proteins 0.000 description 2
- 102000004895 Lipoproteins Human genes 0.000 description 2
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 2
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 240000003768 Solanum lycopersicum Species 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- ANVAOWXLWRTKGA-XHGAXZNDSA-N all-trans-alpha-carotene Chemical compound CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1C(C)=CCCC1(C)C ANVAOWXLWRTKGA-XHGAXZNDSA-N 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 238000000498 ball milling Methods 0.000 description 2
- 235000013734 beta-carotene Nutrition 0.000 description 2
- 239000011648 beta-carotene Substances 0.000 description 2
- 239000003833 bile salt Substances 0.000 description 2
- 229940093761 bile salts Drugs 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 239000006184 cosolvent Substances 0.000 description 2
- 235000020241 curcumin extract Nutrition 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 229940088679 drug related substance Drugs 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 230000001804 emulsifying effect Effects 0.000 description 2
- 210000001842 enterocyte Anatomy 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 231100001261 hazardous Toxicity 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 238000010348 incorporation Methods 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 235000020778 linoleic acid Nutrition 0.000 description 2
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 2
- 239000011859 microparticle Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 239000002159 nanocrystal Substances 0.000 description 2
- 239000006070 nanosuspension Substances 0.000 description 2
- 230000006911 nucleation Effects 0.000 description 2
- 238000010899 nucleation Methods 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 229920002959 polymer blend Polymers 0.000 description 2
- 230000001376 precipitating effect Effects 0.000 description 2
- 238000001046 rapid expansion of supercritical solution Methods 0.000 description 2
- 210000001525 retina Anatomy 0.000 description 2
- 238000013341 scale-up Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 230000007928 solubilization Effects 0.000 description 2
- 238000005063 solubilization Methods 0.000 description 2
- 238000000638 solvent extraction Methods 0.000 description 2
- 230000035882 stress Effects 0.000 description 2
- 229940005741 sunflower lecithin Drugs 0.000 description 2
- 230000001839 systemic circulation Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 239000003981 vehicle Substances 0.000 description 2
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 2
- 150000003735 xanthophylls Chemical class 0.000 description 2
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 2
- JKQXZKUSFCKOGQ-JLGXGRJMSA-N (3R,3'R)-beta,beta-carotene-3,3'-diol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-JLGXGRJMSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- 208000030433 Epiphysiolysis of the hip Diseases 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 241000168517 Haematococcus lacustris Species 0.000 description 1
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 1
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 1
- 235000019774 Rice Bran oil Nutrition 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- JKQXZKUSFCKOGQ-LQFQNGICSA-N Z-zeaxanthin Natural products C([C@H](O)CC=1C)C(C)(C)C=1C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-LQFQNGICSA-N 0.000 description 1
- QOPRSMDTRDMBNK-RNUUUQFGSA-N Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C QOPRSMDTRDMBNK-RNUUUQFGSA-N 0.000 description 1
- USJBGSPHUDEYGM-ZBUGBIPZSA-N [(1r)-4-[(1e,3e,5e,7e,9e,11e,13e,15e,17e)-18-[(1r,4r)-4-acetyloxy-2,6,6-trimethylcyclohex-2-en-1-yl]-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaenyl]-3,5,5-trimethylcyclohex-3-en-1-yl] acetate Chemical compound CC1(C)C[C@H](OC(=O)C)CC(C)=C1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@@H]1C(C)(C)C[C@@H](OC(C)=O)C=C1C USJBGSPHUDEYGM-ZBUGBIPZSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- JKQXZKUSFCKOGQ-LOFNIBRQSA-N all-trans-Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C JKQXZKUSFCKOGQ-LOFNIBRQSA-N 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- 239000011795 alpha-carotene Substances 0.000 description 1
- 235000003903 alpha-carotene Nutrition 0.000 description 1
- ANVAOWXLWRTKGA-HLLMEWEMSA-N alpha-carotene Natural products C(=C\C=C\C=C(/C=C/C=C(\C=C\C=1C(C)(C)CCCC=1C)/C)\C)(\C=C\C=C(/C=C/[C@H]1C(C)=CCCC1(C)C)\C)/C ANVAOWXLWRTKGA-HLLMEWEMSA-N 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 239000002199 base oil Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000011260 co-administration Methods 0.000 description 1
- 238000000975 co-precipitation Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000011246 composite particle Substances 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 229930004069 diterpene Natural products 0.000 description 1
- 150000004141 diterpene derivatives Chemical class 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 230000007515 enzymatic degradation Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000010685 fatty oil Substances 0.000 description 1
- 239000012847 fine chemical Substances 0.000 description 1
- 235000012055 fruits and vegetables Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 235000021474 generally recognized As safe (food) Nutrition 0.000 description 1
- 235000021473 generally recognized as safe (food ingredients) Nutrition 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000007407 health benefit Effects 0.000 description 1
- 239000006049 herbal material Substances 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 230000003116 impacting effect Effects 0.000 description 1
- 210000002490 intestinal epithelial cell Anatomy 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 125000000400 lauroyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000002960 lipid emulsion Substances 0.000 description 1
- 150000002634 lipophilic molecules Chemical class 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 235000004213 low-fat Nutrition 0.000 description 1
- 235000012661 lycopene Nutrition 0.000 description 1
- 239000001751 lycopene Substances 0.000 description 1
- 229960004999 lycopene Drugs 0.000 description 1
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 230000004483 macular pigment optical density Effects 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000003228 microsomal effect Effects 0.000 description 1
- 210000000110 microvilli Anatomy 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 239000007764 o/w emulsion Substances 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 238000010951 particle size reduction Methods 0.000 description 1
- 230000008832 photodamage Effects 0.000 description 1
- 235000017807 phytochemicals Nutrition 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229930000223 plant secondary metabolite Natural products 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 231100000683 possible toxicity Toxicity 0.000 description 1
- 230000000291 postprandial effect Effects 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000009790 rate-determining step (RDS) Methods 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000001226 reprecipitation Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000002207 retinal effect Effects 0.000 description 1
- 239000008165 rice bran oil Substances 0.000 description 1
- 238000012502 risk assessment Methods 0.000 description 1
- 239000012047 saturated solution Substances 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 238000005549 size reduction Methods 0.000 description 1
- 230000003381 solubilizing effect Effects 0.000 description 1
- 238000000194 supercritical-fluid extraction Methods 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 235000010930 zeaxanthin Nutrition 0.000 description 1
- 239000001775 zeaxanthin Substances 0.000 description 1
- 229940043269 zeaxanthin Drugs 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
- A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
- A23D9/007—Other edible oils or fats, e.g. shortenings, cooking oils characterised by ingredients other than fatty acid triglycerides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
- A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
- A23D9/02—Other edible oils or fats, e.g. shortenings, cooking oils characterised by the production or working-up
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B1/00—Production of fats or fatty oils from raw materials
- C11B1/10—Production of fats or fatty oils from raw materials by extracting
- C11B1/104—Production of fats or fatty oils from raw materials by extracting using super critical gases or vapours
Definitions
- this invention describes a molecular dispersion of lipophilic nutrients such as carotenoids, curcumin, ginger, omega 3 fatty acids, tocopherols, tocotrienols, vitamin A, K and the like. More particularly, this invention describes a molecular dispersion of lipophilic nutrients in an oily matrix such as sunflower oil, safflower oil, soybean oil, corn oil, canola oil, castor oil, ground nut oil and the like. Dispersion of lipophilic nutrients in an oily matrix is enabled through supercritical carbon dioxide as a solvent under certain conditions of pressure, temperature and duration of mixing. Molecular dispersion of bioactive may further be stabilized by the addition of a stabilizer and additives which will enable homogenous dispersion.
- lipophilic nutrients such as carotenoids, curcumin, ginger, omega 3 fatty acids, tocopherols, tocotrienols, vitamin A, K and the like.
- an oily matrix such as sunflower oil, safflower oil, soybean oil, corn oil
- the Molecular dispersions of lipophilic nutrients in a lipid matrix have applications in enhancing the absorption and bioavailability. Molecular dispersions of lipophilic nutrients in lipid matrix also stabilizes the lipophilic nutrient by protecting them from oxidation, stomach acid, digestive enzymes, and microsomal enzymes. At a molecular level, by using certain lipid matrix, it is possible to enhance lymphatic absorption and minimize portal absorption. Background of the Invention The plant bioactives particularly carotenoids are poorly soluble in lipophilic carriers such as oils. To improve the Bio-delivery of plant derived bioactives several strategies have been attempted by different researchers.
- aqueous solubility of the nutraceutical bioactive is important and will determine the bioavailability and availability of bioactive for systemic absorption via biological membranes.
- the drug substances including bioactive have the bioavailability problem mainly due to the low aqueous solubility and the rate limiting step is the dissolution process. Therefore, for improvising the solubility in lipid medium and to some extent in aqueous medium, the selection of proper additives for targeted delivery of bioactive is very decisive to overcome the major obstruction in bioavailability and absorption.
- the molecular dispersion of a bioactive is an emerging field and could be achieved through particle design through different techniques including SCF-CO2.
- the specially designed SCF-CO2 equipment could be applied for particle designing which are very cost intensive.
- the focus is to achieve the target through the SCF-CO2 extraction vessel, designed for high pressure extraction.
- the design modification done to disperse the bioactive molecules at high pressure and optimized temperature leads to the dissolution/dispersion of bioactive molecule.
- the dispersed bioactive in lipid matrix will result in higher bioaccessability thereby improving the bioavailability of the bioactive nutraceutical compounds as the higher amount of bioactive will be made available in the gastro- intestinal lumen for absorption in the intestine.
- the bioactive carotenoids need to be released from its food matrix and incorporated and dissolved into a hydrophobic medium (bulk lipid emulsion, or mixed micelles).
- a hydrophobic medium bulk lipid emulsion, or mixed micelles.
- the lipid matrix prepared in such a way with green solvent in to a molecular dispersion will lead to digestion in the GIT and supporting intestinal lymphatic transport. This process may lead to bioactive supersaturation, leading to increased absorption. Therefore, the aim of the present invention is not only to improve the bioavailability of the bio-actives but also to make it amenable to bio- delivery. This is aimed to target the lymphatic absorption of the bioactive and bypass the first pass metabolism. Conventionally to improvise the bioavailability of the bioactives which are mainly poorly water-soluble lipophilic compounds, the process of improving solubility/bioavailability through high-speed homogenization, homogenization in oils, milling and salt formation is attempted.
- the colloidal milling or ball milling are again may result in stress impacting the stability of bioactive compounds.
- the conventional method of molecular dispersion achieved with high pressure homogenization, ball milling and colloidal milling will result in reduction in the size of bioactive compound in micron and sub-micron level with increased surface area, which will ultimately lead to better and faster diffusion/ absorption.
- the process of homogenization will have limitation for thermos-labile carotenoids and xanthophyll’s as the physical stress may cause thermal degradation.
- controlling shape, size and morphology of the particles is also not easy.
- Another limitation of the process is the use of high concentration of surfactants and co- surfactants to make the lipid dispersion.
- the aim of particle design of the plant bioactive particularly carotenoids and xanthophyll was to achieve the lipid matrix which is dispersed and have better bio-delivery to the targeted organs.
- the process of preparing the improved bioavailable oil solution with vegetable oils and with the application of SCF-CO2 is described as SCEMOD Super Critically Enabled Molecular Dispersion.
- the technology as named for the process of preparing molecular dispersion of the bioactive compounds in vegetable oils and making the use of high pressure SCF-CO2 for enabling molecular dispersion.
- the oil used for extraction/ dispersion/dilution media may additionally contain stabilizers which stabilizes the molecular dispersion.
- the SCF-CO2 extraction/enrichment is attempted in two stage process.
- the oil used for dilution is 0.5-1.5 Volume of the SCF-CO2 extract and generally added as per the strength of bioactive (content & mass), phospholipids and polyethylene glycol and may also contain 0.1-5% Polysorbate 80.
- the process was done in the SCF-CO2 by adding the vegetable oil to the plant bioactive, i.e., lutein ester, Astaxanthin and or turmeric extract, thereafter, conducting SCF-CO2 homogenization /extraction at 125-900 bar and temperature varying from 40-70 degree Celsius with Co2 flow rate of 0.5-2.0 Kg/min.
- the process further led to the removal of waxes and resins along with the water from the marigold meal by a two-stage extraction, i. e. at 150-300 bar and 50-70 degree Celsius followed by extraction at 450-900 bar and temperature 40- 70 degree Celsius.
- SCF-CO2 For the extraction and particle of botanical extract with the vegetable oils SCF-CO2 led to the molecular dispersion.
- the lipid matrix contains homogenous sub- micron particles which result in improved dispersion.
- the targeted molecular dispersion with different vegetable oil particularly olive oil is aimed to make the bioactive more bioavailable in the similar lines with the study conducted by Food research foundation on lutein, which showed that when fed with different oils, the mice fed with olive oil gave the highest absorption rate lutein in the intestinal tract.
- the Current invention also focusses on the making the product stable and amenable to lymphatic absorption by the use of natural oils and particle sizing to make sub-micron particles for uniform dispersion by the application of high pressure super critical carbon dioxide.
- the conventional method of particle sizing for making liquid dispersion to improve the bioavailability of bioactive have the limitation of such as formulation instability, broad particle size distribution, and low drug loading efficiency.
- Solvent extraction into supercritical CO2 leads to the precipitation of lipid/drug material, which is dissolved as composite particles.
- One of the advantages of this technique is the high solvent extraction efficiency of supercritical CO2, compared to conventional methods, which allows the solvent to be quickly and completely removed and a more uniform particle size distribution to be achieved.
- the method of nano-suspension preparation the rapid expansion of supercritical solvent consists of two stages, i) dissolving the solid substance in a SCF and ii) formation of particles due to supersaturation.
- SCF-CO2 is pumped at desired pressure and temperature to extraction chamber containing solid substance(s) through heat exchanger.
- the SCF percolates and dissolves the solid substance(s) in the extractor and then the resulted solution is depressurized through a heated nozzle or capillary at supersonic speed into a low-pressure chamber.
- the expansion of the supercritical solution leads to rapid drop in temperature and pressure and formation of droplets/ particles.
- the method of rapid expansion of supercritical solution explains the process of particle formation of smaller-sized droplets (SEDS) at the tip of the nozzle.
- SEDS smaller-sized droplets
- the nozzle and its specifications play a critical role during SEDS processing, which can be altered to adjust the jet breakup for fine particle formation (Zohra et al 2022, Garcia casas 2020, Deepika Purohit 2020, A M Vorobei 2021, Michael turk 2022 and Sandip Roy et al 2021).
- atomizer such as coaxial nozzles, internal twin-fluid mixing nozzles, four-pinhole nozzle, and an annular gap nozzle.
- the process is different from the conventional supercritical dispersion as it utilizes a specialized prefilming twin-fluid atomizer that increases the mass transfer rate between the SCF and the solution feed.
- the surrounding molecules of the solute in the medium then start accumulating over the nucleus, and the crystal growth ultimately ends with agglomeration.
- the process is utilized to prepare uniform sized fine particles in single phase equilibrium.
- the Bioactive nutraceutical/ and or excipient are dissolved in suitable organic solvent by vigorous mixing and thereafter rapidly sprayed over SCF through a coaxial nozzle into a high-pressure vessel leading to uniform small sized droplets due to jet breakup at the tip of the nozzle.
- these are very capital-intensive process and require high capital investment and currently scale up of the same is yet to be implemented.
- the SCF-CO2 process utilized for extraction of phytochemicals from plants has been studied for preparing molecular dispersion of the bioactive.
- the process is defined as Supercritical enabled molecular dispersion/solution SCEMOD.
- the process utilizes application of vegetable oils particularly palm, sunflower and olive oil.
- the plant nutraceuticals are extracted by SCF-CO2 with single extractor and three separators.
- the extraction conducted at a pressure of from 125-900 bar and most of the trials attempted with 250-900 Bar and 40-80 degree Celsius temperature.
- the biomass is placed in extractor and CO2 is passed at a rate of 0.5 to 1.5 Kgs/minute.
- the extraction is conducted by passing 70-100 Kgs SCF-Co2 per Kgs of biomass.
- the extracted mass is separated and collected.
- This extract is mixed with vegetable oil ranging from palm oil, canola oil, Sunflower oil and olive oil in a ratio of 0.5:1.5 of the extract.
- the dispersion of bioactive in the palm, sunflower and olive oils lead to the molecular dispersion.
- the addition of plant derived phospholipids particularly sunflower lecithin, tocopherol and lower molecular weight polyethylene glycol in a ratio of 0.5-5% were used to further stabilize the molecular dispersion.
- the molecular dispersion prepared in this way may also contain 2-80% stabilizers.
- the oil dispersion is further homogenized in SCF-CO2 by passing SCF-CO2 at rate 0.6-0.8 kg/min at a pressure range of 70-130 bar and 45-60 degree Celsius.
- the mixing and homogenization in SCF-CO2 vessel carried for 1-1.5h.
- the homogenized mass is collected and observed under microscope.
- the microscopic pictures show particle uniform dispersion after mixing with oils and stabilizers.
- the SCF-CO2 process for extraction and isolation of nutraceutical bioactive overcome the process of solvent residue in the particle designed as devoid of hazardous solvent residue which pose major risk to the health of consumers.
- the processing thermo-labile compounds may result in degradation or quality deterioration for preparation of lipid matrix of lipophilic bioactive involves the application of high quantity of surfactants and oils which are absorbed and pass to liver.
- the bioavailability is very low as the bioactive are metabolized and shows very less active for the health benefits.
- the supercritical fluid carbon dioxide is used as extraction and solvent for particle designing.
- the supercritical carbon dioxide is environmentally safe and sustainable solvent and overcome the issue of hazardous solvent in the extracted bioactive.
- the current method proposes the use of carbon dioxide for particle designing by preparing the bioactive in molecular dispersion.
- the aim of preparing the stable nutraceutical oil suspension is to make stable oil suspension of oil insoluble bioactive for pharmaceutical or nutraceutical applications.
- the pre-requisite for the stable oil suspension is to bring the oil insoluble ingredients in homogenous suspended form. For long period of time and even if some active settles that could be reconstituted to original homogenous form by slightly mixing.
- Another approach to prepare oil suspension is by intimate mixing or blending of marker bioactive to be suspended in oil by reducing the suitable particle sizing before suspending in vegetable oils.
- oil dispersion enabled with the SCF-CO2 could adhere to the intestinal mucosa thus the contact time of the bioactive dispersed will have enhanced absorption.
- the stability of oil dispersions needs to be taken utmost care and require vast formulation skills to ensure the physical stability.
- the accuracy of doses needs to be ascertained and reliability needs until the suspension is packed in unit doses form.
- the oil dispersions may be bulky for transport and needs to be shaken each time before measuring a particular dose.
- the conventional method of making oil suspension utilize surfactant and co-surfactant in high quality sometimes 100-300% of the bioactive or sometimes same quantity of the bioactive nutraceuticals.
- the oil dispersion prepared in such a way for food application may suffer from the fact of potential toxicity of the surfactant used in high quantity due to the perturbation of intestinal epithelial cells even with the ingredients having GRAS status.
- the oil dispersions prepared by conventional method the risk assessment is necessary due to the intact bioactive delivery system into the systemic circulation is unlikely due to the intestinal and gastric digestion.
- the use of RESS and SAS nozzle technologies are yet to be commercially used and require high investment.
- the amount of bioactive dissolved in oil matrix is typically as low as 1%. Therefore, all these issues could be addressed with the used of supercritical enabled molecular dispersion. Further the existing process of making lipids dispersion of bioactives led to transport of bioactives via the portal vein.
- bioactives therefore immediately accumulate in the liver and are then metabolized by enzymes, which lowers the concentration of bioactives in the bloodstream.
- a number of studies conducted showed that the nutraceuticals taken orally typically show low bioavailability due to their degradation by enzymes in the gastrointestinal (GI) tract, and difficulty of absorbing them in the small intestine and the first-pass metabolism in the liver. After oral administration, the bioactives pass through the small intestine and enter the portal vein to liver. Therefore, the metabolism of the nutraceutical bioactives led to very low bioavailability.
- Another limitation of conventional preparation of lipid dispersion is entrapment of nutrients and bioactive in the lipoproteins resulting in increased the concentration in the plasma.
- the lymphatic absorption of carotenoids could deliver the bioactive carotenoids to the target tissues in more active form. This could be accomplished by preparing the carotenoids molecular dispersion in vegetables oils.
- the dietary nutrients including carotenoids are absorbed in the small intestine and intestinal lymphatic system is used to absorb lipids and dietary lipophilic vitamins as the form of chylomicrons.
- the molecular dispersion of carotenoids avoids the first pass metabolism. Therefore, owing to the property of olive oil as a carrier for bioactives for lymphatic transport and bypass the first pass metabolism the current invention focusses on the use of vegetable oils particularly olive oil and SCF-CO2 to enable the molecular dispersion for better efficacy and bioavailability.
- SCEMOD technology converts crystals of lipophilic nutrients into molecular dispersion in an oil carrier. It is different from nanocrystals and nanoparticles, wherein an antisolvent/lipid matrix - or a polymer is required to convert the solution of lipophilic nutrient into nanoparticles or nanocrystals.
- SCEMOD cannot be compared with RESS (Rapid Expansion Supercritical Solution). Since SCEMOD does not require use of a nozzle or expansion chamber or precipitation chamber.
- SCEMOD is differentiated from SNEDD (Self-Nano Emulsifying Drug Delivery) because the SNEDD essentially contains a surfactant and/or cosolvent such as methanol/ethanol. SCEMOD can be achieved with just an oil carrier and supercritical co2.
- SCEMOD is more of a solubilization technique in lipid phase with the help of SCF CO2.
- SNEDD basically requires that the nutrient should be dissolved in oil phase or cosolvent or surfactant. Products such as Lutein/Curcumin have very low solubility in oils, surfactants and co-solvents. After applying SCEMOD, one can achieve required solubility in oil phase and then proceed with SNEDD to achieve nano-emulsion upon ingestion.
- SCF CO2 + Olive Lut oil The process of molecular dispersion in lipid matrix for bioactives prepared with food grade vegetable oil and SCF-CO2 is developed as platform technology for different carotenoids, xanthophyll’s, Polyphenols and Diterpene and Omega-3 fatty acids.
- the process was developed specifically or marigold lutein ester, Turmeric extract powder, Ginger rhizome extract, Astaxanthin and for all fat-soluble nutrients like tocopherol, tocotrienols, Omega-3 fatty acids, carotenoids like lycopene, Vitamin A, D and K and other similar Bioactives.
- this technology can also be applied to lipophilic drugs, fine chemicals and speciality chemicals.
- the application of platform technology may help to enhance the bioavailability of poorly soluble lipophilic drug molecules.
- the marigold extract, turmeric extract powder, Astaxanthin and lutein were modified with the help of vegetable oils and Supercritical fluid-CO2 in a modified SCF- CO2 unit at different temperature and pressure.
- US 6,620,351 B2 The current invention relates to a method for the production of micron or nanometer size particles by precipitation, wherein a dispersion containing the substance of interest is contacted with a Supercritical fluid anti-solvent under near or Supercritical conditions in order to maximize micro or nanoparticle formation.
- the invention also provides techniques to control the particle size, particle Size distribution and particle morphology.
- the invention also includes Super critical fluid coating or composite material particle formation, wherein encapsulation of one Substance by another Substance or co-precipitation of more than one Substance in the form of micro or nanoparticles are achieved in the Supercritical fluid anti-solvent.
- AU-B 70071194 Method and Apparatus for formation of particles -
- the invention provides a method for the formation of a product which comprises co-introduction of supercritical fluid and a vehicle containing at least one substance in solution or suspension into a particle formation vessel, the temperature and pressure are set and controlled such that dispersion and extraction of the vehicle occur simultaneously by the action of supercritical fluids.
- the invention also describes product formation and such method for the same and a vessel for carrying out the process.
- the process of the cited invention results in particle reduction and not solubilization.
- the dispersion method is characterized by carrying out the dispersion by using a supercritical solvent in a supercritical state as a dispersing means.
- the present invention also relates to a dispersing apparatus for the dispersion method.
- the disadvantage of the cited invention lies in the use of organic solvent while the current invention deals with the green SCF-CO2 for this purpose.
- CA 2933086C 2016, describes a pharmaceutical composition comprising a chylomicron and a carotenoid. suspended in an aqueous solution and suitable for intravenous administration.
- the bioavailability of the carotenoid of the pharmaceutical composition is higher relative to the bioavailability of free carotenoid.
- EP0728037A1 Method of forming particles using a supercritical fluid, aerogel particles formed thereby, and antiperspirants containing aerogel particles, Gillete Co Inc, 1994:
- the current invention focuses on the lipophilic lipid matrix for dispersion/ dissolution of bioactive molecules.
- a method for providing aerogels, and aerogels produced according to the method is described.
- antiperspirant compounds that are in aerogel form, and antiperspirant and deodorant compositions including such salts are described. The method involves contacting a solution containing material to be processed with a species selected to precipitate the material and selected so as to be miscible with the solvent system of the solution.
- the material may be washed with the precipitating species until it is substantially free of solvent system. Then, the precipitating species containing the material precipitate is taken above its critical point, and the supercritical fluid is exhausted above its critical temperature.
- This reference does not disclose a method to make a molecular dispersion or true solution of lipophilic bioactives.
- US Patent 9622497 The process describes a method of preparation of carotenoid oil suspension by and preparation: a) mixing carotenoid with organic solvent, heating the mixture to dissolve the carotenoid sufficiently to obtain carotenoid solution; b) introducing the carotenoid solution obtained in step a) into a vegetable oil solution stirred in high speed by spraying, meanwhile recovering the organic solvent generated during spraying under vacuum condition, then, simultaneously completing recycling and spraying, thereafter, obtaining carotenoid oil suspension; wherein, the carotenoid oil suspension comprises a carotenoid crystal with an average particle size of less than 5 ⁇ m.
- the method is applicable in industrial scale with continuous operation and increased efficiency without additional carotenoid crystal grinding processes and decreases the degradation of carotenoid during the preparation process of carotenoid oil suspension.
- the patent describes use of organic solvent for dissolution of carotenoids and results in a suspension of 5-micron crystals. Not comparable to the current invention which focusses on forming a molecular dispersion in oils.
- EP 2468111A 1- The process describes a composition of carotenoids improved absorption and bioavailability.
- the process involves preparation of Micellation of xanthophylls after melting Lutein diacetate or Lutein dipropionate in their natural original lipid vegetable matrix, in the presence of lipids, phospholipids, fatty acids, emulsifiers and moisture, and are ingested in a dosage between 2 to 50 mg, to provide an absorption of the carotenoid solubilizate which is at least 20% above than that of crystalline carotenoids, and provides a macular pigment deposit which exceeds at least 10% of Macular Pigment Optical Density, than the deposition obtained by ingesting crystalline Lutein.
- the formulation developed might prevent tissue degeneration, UV light damage to skin and the retina, and in general to act as more effective and efficient antioxidants than when administered in crystalline form.
- the cited document describes the comparison of crystalline carotenoid and one in presence of phospholipids, emulsifier, and fatty acids where up to 50 mg of bioactives solubilize, in comparison current investigation aims to prepare lipid matrix of bioactive in vegetable oils and SCF- CO2 to make molecularly dispersed matrix/ true solution at much higher concentration such as 20%, which will have higher absorption and thereby the bioavailability.
- EP0814112 A2 Surfactants for heterogeneous processes in liquid or supercritical CO2 Keith P. Johnston,1996 Steven P.
- Heterogeneous polymer mixtures comprising a polymer in liquid or supercritical CO2 are stabilized by employing a poly (propylene oxide) or poly(butylene oxide) based surfactant.
- These surfactants are especially well suited for stabilizing heterogeneous polymer mixtures formed by micronizing techniques as well as by precipitation of a compressed fluid antisolvent applications.
- the patent describes use of surfactant in high quantity, which is unacceptable in nutrition industry, while current invention describes the molecular dispersion of bioactive in lipid matrix which high payloads.
- EP1547679 B1 The invention relates to a method of applying high-intensity ultrasound in order to accelerate and improve the efficiency of the mass transfer method in supercritical fluids.
- the inventive method comprises the contact separation of a substance containing components that can be extracted with a solvent under supercritical conditions or conditions close to the critical point.
- the invention also relates to a device which has been developed in order to carry out said method and which is based on the generation of an intense stationary ultrasonic field inside a standard pressurized container for supercritical fluids.
- the invention further relates to the use of the inventive method for the separation or extraction of natural products which can be used in, for example, the agri-food, chemical, cosmetic and pharmaceutical sectors.
- the process of cited patent focusses on the mass transfer for better isolation while current method describes molecular dispersion of bioactives in lipophilic oils and SCF-CO2.
- the inventive method comprises the administration of one or more lipid Soluble compounds in conjunction with a structured glyceride component containing at least 33 wt.% of a fatty acid moiety having 4 to 12 carbon atoms, at least 30 wt. % of a fatty acid moiety having more than 12 carbon atoms and an equivalent carbon number (ECN) greater than 30 to less than 48.
- ECN equivalent carbon number
- the intestinal lymphatic pathway can bypass first- pass metabolism in the liver, thus increasing drug bioavailability. Furthermore, the co- administration of drugs with lipids can enhance their lymphatic transport.
- lipid–drug conjugates and lipid-based nanoparticles have been widely studied for the delivery of lipophilic drugs via the lymphatic pathway. This will increase the active concentration in the blood plasma which will have more beneficial health impact.
- nutraceutical bioactives are homogenized with olive oil under supercritical condition which converts the bioactives to molecular dispersion and transported to the targeted delivery.
- oleic acid micelles and olive oil enhance the intestinal accessibility of carotenoids more than linoleic acid micelles or vegetables oils rich in polyunsaturated fatty acids (PUFA).
- PUFA polyunsaturated fatty acids
- the current work also focusses on the use of lipophilic oils particularly olive oil for targeting lymphatic absorption to improve the bioavailability.
- Rangaswamy Lakshminarayana and Valiikanan Baskaran 2013 found the Carotenoids incorporated into the lipid phase, are emulsified into small lipid droplets in the stomach and transferred further to mixed micelles formed by the action of bile salts, biliary phospholipids, dietary lipids, and their hydrolysis products.
- H Tapiero 2004 found that the mixed micelles containing carotenoids migrate through the brush border by simple diffusion, where carotenoids are absorbed by the intestinal enterocytes, packed into chylomicrons, and secreted to the lymphatic system for circulating in the blood stream studied that the carotenoids on digestion are incorporated into the lipid phase and then are emulsified into small lipid droplets.
- the nature and amount of lipids in the diet greatly affect the emulsification, secretion of bile salts, and formation of mixed.
- oleic acid micelles and olive oil enhance the intestinal accessibility of carotenoids more than linoleic acid micelles or vegetables oils rich in polyunsaturated fatty acids (PUFA).
- PUFA polyunsaturated fatty acids
- micellarization was found to increase the intestinal digestion of beta carotene in presence for various lipids in the order of soybean oil > olive > canola > butter,
- the carrier oil impact was not reported as studies by Failla Mark Chitchumronchokchai, Chureeporn,Ferruzzi Mario G, Goltz Shellen R 2014.
- US Patent 4048203 describes a method for producing a 1% solution of lutein-fatty acid ester by dissolving in hot mono- and diglycerides. The resulting solution is homogenized with an equal volume of 0.5% solution of Polysorbate 80 (TWEEN" 80, ICI United States Inc., Wilmington, Delaware 19897). The emulsion thus produced can be used for coloring ice cream by direct addition to mixing.
- the above reference has a limitation of low concentration, such as 1% in solution form. Moreover, it makes use of an organic solvent to solubilize lutein ester, which is unacceptable in nutrition industry.
- the invention describes a molecular dispersion or true solution of lipophilic bioactives in oil matrix in high concentration such as 20% which is made possible through application of supercritical fluid carbon dioxide.
- the invention further provides for method by which the molecular dispersion is stabilized, such that upon ingestion, the molecular dispersion instantly forms a Nano-emulsion in stomach without allowing crystallization of lipophilic bioactive.
- a method for preparing molecular dispersion of a lipophilic bioactive in a lipid matrix comprising the step of: extracting the lipophilic bioactive material with food grade oils (lipid matrix) into a supercritical carbon dioxide (SCF-CO2) extraction vessel; mixing and homogenizing the plant bioactive material with the food grade oils by passing the supercritical carbon dioxide (SCF-CO2) in the extraction vessel, at a specified pressure and temperature for a time duration of 2-3h; stabilizing the molecular dispersion of lipophilic bioactive material with the help of stabilizers and additives; wherein, the supercritical carbon dioxide (SCF-CO2) extraction vessel incorporates tubing and rings that facilitates the uniform distribution of carbon dioxide during extraction and molecular dispersion process, and results in sizing of the particle to molecular level which makes the dispersion homogenous.
- SCF-CO2 supercritical carbon dioxide
- the lipophilic bioactive material is extracted from the plant material.
- the plant material having particle sizes ranging from 1-4 mm.
- the above mentioned method further includes a step of conducting microscopic observation to verify the quality of the molecular dispersion.
- the lipophilic bioactive material and food grade oils (lipid matrix) in SCF-CO2 extraction vessel in a proportion 1:0.5 to 1:1.
- the lipophilic bioactive material selected from the group consisting of lutein ester, turmeric extract powder; curcumin 95%, and astaxanthin, and wherein the lipophilic bioactive material are present in a ratio of 1:0.5 to 1:1 with respect to the food grade oils.
- the molecular dispersion of the bioactive material is performed at a pressure having range from 60-900 bar. In accordance with one embodiment of the present invention, the molecular dispersion of the bioactive material is performed at a temperature having range from 40-80 degree Celsius.
- lipophilic bioactive material selected from the group consisting of carotenoids, curcumin, ginger, omega 3 fatty acids, tocopherols, tocotrienols, Coenzyme Q10, Vitamin C palmitate and vitamin A, K and the like.
- said food grade oils (lipid matrix) is selected from the group consisting of sunflower oil, safflower oil, soybean oil, corn oil, canola oil, castor oil, ground nut oil, palm and the like.
- the antioxidants and stabilizers are present in an amount from 0.2 to 0.5%, and 2-20%, respectively.
- the antioxidants and stabilizers are selected from tocopherol, ascorbyl palmitate, rosemary extract, and the like.
- said additives includes PEG 400, and plant-derived phospholipids.
- the stabilizers added in step (c) range from 2% to 80% by weight to improved water dispersibility of the bioactive.
- the supercritical carbon dioxide (SCF-CO2) extraction vessel comprises high-pressure CO2 pumps which delivers CO2, at flow rates ranging from 0.5 to 2.0 Kg/min.
- the method for the preparation of composition is aimed at the lymphatic transport of SCEMOD preparation and specially target retina with the application of higher chain fatty acids like palm oil, sunflower oil and olive oil.
- the retinal target is accompanied by improved bioavailability with the mixing of palm oil, sunflower and/or olive oil to the botanicals for preparing molecular dispersion.
- a composition comprising: a lipid matrix formed of a food or pharma grade oil in an amount from 40 to 50 percent by weight of composition; a lipophilic bioactive dispersed at a molecular level in the lipid matrix, wherein the lipophilic bioactives are present in a concentration of at least 20%; and a stabilizer and additives for enhancing the homogenous dispersion and stability of the lipophilic bioactive in the lipid matrix, said stabilizer are present in an amount from 2 to 20 percent; wherein the composition is prepared by using supercritical carbon dioxide as a solvent, the composition is prepared by dispersing the lipophilic bioactive in the lipid matrix at a molecular level in an extraction vessel that operates within a pressure range of 125-900 bar and a temperature range of 40-80 degrees Celsius.
- the current invention mentions the preparation of molecular dispersion of bioactive nutraceuticals with oil and SCF-CO2 in a specially designed SCF-CO2 equipment.
- the plant material is run in SCF-CO2 with oils for solubilizing the bioactives in presence of SCF-CO2.
- the extractor is modified by adding small mixing SS tubes/packings which help in uniform distribution of Carbon dioxide during extraction/ molecular dispersion.
- the specific experimental trials for preparing molecular dispersion are described below.
- the marigold meal processed from marigold flower is input for conducting SCF-CO2 extraction at different pressure and temperature.
- the initial stage involves removal of oil and waxes followed by extraction to get enriched content lutein ester in the SCF_CO2.
- the enriched lutein ester-marigold extract is homogenized with vegetable oil ranging from palm oil, MCT oil, Soybean oil, Sunflower oil and olive oil to get lutein ester dispersed in the oil.
- the dispersion of marigold extract done with the SCF-Co2 is further added stabilizer and additives and further run in SCF-CO2 at specified temperature and pressure.
- Botanicals for preparation of SCEMOD were grinded to make particle size ranging from 1-4mm and the same was loaded to the SCF-CO2 extraction vessel, 12L capacity.
- the jacket heating is conducted with hot water circulation.
- the extraction parameter were set 250-900 bar pressure and 40-80 degree Celsius temperature.
- For enabling extractionSCF-CO2 is passed at a rate of 0.5 kgs-2.0/minute.
- the total Co2 passed is generally depends upon the nature of herbal material and the particle size.
- the extraction material is collected in the separator-1 while the lower content extract is collected in separator-2 while oil and waxes are collected in separator-3.
- the temperature and pressure of three separators is set depending on the nature of purification required.
- the separator -1, separator-2 and separator-3 are maintained at a pressure ranging from 90-350 bar and 50-70 degree celsius, 50-140 bar and 45-50 degree Celsius and 40-70 bar and 10-15 degree celsius respectively.
- the High-pressure extractors as used in the present investigation are designed independently as parallel systems connected each to independent high pressure CO 2 pumps having CO 2 flow rate up to 0.5-2.0 Kg/min with a design pressure of both pumps and extractors 900 bar while the respective H.P, M.P and L.P separators are designed to pressures of 450-600, 240-350 and 83-110 bar.
- the extraction of botanical powder form of 1-4 mm particle size is conducted by placing the botanical in a basket which is further loaded into an extractor vessel.
- the extractors are confined to various extraction pressures between pressures of operation 150-600 bar specifically 250-590 bar while temperatures are controlled using heat exchangers in-between 45- 65 0 C.
- the extractions are also attempted at a temperature higher than 65 0 C, for the purpose of invention, higher temperatures 80 0 C are not preferable as the facts that the carotenoids are highly susceptible for temperatures and oxygenated-air.
- the pressure parameters of each extractor and separators are regulated to maintain the set pressure conditions by high pressure auto control valves in concordance of temperatures regulation through heat exchangers.
- Separator-1 collect lutein ester with high content 25-35 % while separator-2 contain Lutein ester content from 8-15% and separator-3 contain 1-2% lutein ester.
- the vegetable oils are added to the marigold meal however the collected extract contain lower content of lutein ester generally in the range of 15-20%.
- two phase extraction was carried out first conducting the extraction at 250-590 bar and collecting the lutein ester in separator-1, While the lutein ester with lesser content is collected in separator-2 while oil and water is collected in separator-3.
- the extract thus obtained is mixed with vegetable oil (1:0.5 to 1:1) ranging from sunflower oil, Palm oil, Soybean oil and olive oil.
- Stabilizers and antioxidants are added to the oil suspension to get the homogenous molecular dispersion.
- the SCF-CO2 is passed at a Flow rate of 0.5-0.8 Kg/minute and the homogenization temperature and pressure are set a 90-160 bar and temperature 45-65 degree celsius.
- SCF-CO2 is passed approximately 40-50 kgs/h of the bioactives taken for molecular dispersion through homogenization.
- SCf_Co2 After passing the required amount of SCf_Co2 the homogenized oil dispersion is collected and observed microscopically. Astaxanthin extracted from Haematococcus pluvialis at a pressure of 590-900 bar and 45-60 degree Celsius is filled to the extraction vessel.
- Vegetable oil sunflower, palm oil, and olive oil are used alone individually.
- the oil is added to the SCF-CO2 extract in a proportion of 0.5-1.5 volume and homogenization conducted. After passing and maintaining at a pressure of 100-110 bar and temperature 45-60 degree celsius the homogenized molecular mass is collected. The microscopic observation is conducted. All the molecular dispersion of nutraceutical may or may not added stabilizer to improvise the water dispersibility of the bioactives. In the current work the stabilizers used 2-80%to ensure the better dispersibility.
- the antioxidants ranging from tocopherol, ascorbyl palmitate, rosemary extract along with pharmaceutical additive PEG 400 and plant derived phospholipids, sunflower oil used also used.
- FIG 2 discloses a SCF-CO2 Extraction Equipment for preparing molecular dispersion, in accordance with one embodiment of the present invention.
- the SCF-CO2 extraction vessel was modified for better distribution of extraction solvent SCF-CO2.
- the S-S tubing’s and rings were used at the bottom and towards the periphery of the vessel to pass the pressurized CO2 under supercritical condition for particle modification and produced properly dispersed mass in liquid matrix.
- the SCF-CO2 extraction of bioactives The analysis of lutein ester content in the dispersed mass is carried out by UV-Vis spectrophotometer as well as by High pressure liquid chromatography method.
- Example 1 2 kgs marigold meal is loaded to SCF-CO2 basket and extraction conducted at 550-770 bar pressure and 55–70 degree Celsius temperature.
- the SCF-CO2 is passed at a rate of 0.6-1.0 Kgs/min for one hour.
- the marigold oil containing waxes and water is separated in three separators.
- Example 2 2 kgs marigold meal is loaded to SCF-CO2 basket and two stage SCF-CO2 extraction was conducted at 125 -250 bar and 550 Bar temperature, 65-73 degree celsius and 65- 70 degree celsius respectively.
- the SCF-CO2 is passed at a rate of 0.8-1.2 Kgs/min for 2-3 hour.
- the marigold extract is collected in separator-1 and oil and water is collected in separator-2 and separtator-3 respectively.
- the extract is collected and analysed by Spectrophotometry and shows 6.78% Lutein ester in first stages while the lutein ester in second stage is 32.03%.
- the first stage extract shows molecular dispersion in water while second stage shows lesser dispersibility.
- Example 3 2 kgs marigold meal is loaded to SCF-CO2 basket and two stage SCF-CO2 extraction was conducted at 325 bar and 750 Bar temperature, 65 degree celsius and 65-70 degree celsius respectively. The SCF-CO2 is passed at a rate of 0.8-1.2 Kgs/min for 1.5 hour. The marigold extract is collected in separator-1 and oil and water is collected in separator-2 and separtator-3 respectively. The extract is collected and analysed by Spectrophotometry and shows 9.0% Lutein ester in both the stages with good dispersibility.
- Example 4 2 kgs marigold meal is loaded to SCF-CO2 basket with the addition of 200g ethanol and 200g olive oil to it and SCF-CO2 extraction was conducted at 550-800 bar pressure and 65-70 celsius temperature.
- the SCF-CO2 is passed at a rate of 1.0-1.1 Kgs/min for 2.5 hour.
- the marigold extract is collected in separator-1 and oil and water is collected in separator-2 and separtator-3 respectively.
- the extract is collected and analysed by Spectrophotometry and shows 12.16% Lutein ester with slight dispersibility.
- Example 5 Extract obtained from two stage extraction having bioactive content 40% is further charged in SCF-CO2 liquid-liquid extractor and further added vegetable oils sunflower, MCT, Soybean, palm and olive oil, the CO@ is run on dynamic mode at a pressure 120 bar and 50 degree celsius for 1-1.5h.
- the extract shows good dispersibility.
- the extraction data is presented in Table 3.
- the extract is further added 210-35% stabilizers for enabling complete dispersion.
- the extract so obtained shows excellent dispersibility in water as presented in microscopic figures.
- Example 6 The marigold extracts as obtained in Example2 is further charged in SCF-CO2 liquid- liquid extractor and added olive oil 0.8 to 1.0 volume of marigold extract and homogenized by passing SCF-CO2 at a flow rate of 1 kg/minute for one hour. This results in a homogenous molecular dispersion of marigold meal extract.
- the extract is further added stabilizers and antioxidants to further improvise the dispersion.
- Tocopheryl acetate at 0.2-0.5% of the extract, Sunflower lecithin 2-3%, Polysorbate 80, 1-2% and Koliphor RH 40 at 12-30% of the extract Volume of the extract charged.
- SCF-CO2 is passed at a rate of 0.5-1.0Kg/min for 1-1.5 hour at a pressure ranging 80-100 Bar and temperature 40-50 degree celsius to get homogenous molecular dispersion.
- the extract is unloaded from the extractor and content of lutein ester measured by spectrophotometry.
- the lutein ester content is 15.6%.
- Example 7 300g curcumin extract 95% is added 1100 g MCT oil and placed in SCF-CO2 liquid extract for enabling the molecular dispersion.
- the pressure and temperature are controlled at 180 bar and 70 degree celsius.
- SCF_CO2 is passed at 1kg/minute and total 80 kgs SCF-CO2 is passed.
- Example 8 500g Curcumin extract 95% is added 1800g olive oil and charged to SCF-CO2 extractor. The extraction/ molecular dispersion trials were conducted at 180 bar pressure and 80degree celsius temperature. For enabling the dispersion 120 kgs SCF-CO2 is passed at a flow rate of 1.0 Kgs/minute. The extract shows 20.1% curcumin content as presented in table 5.
- Example 9 For enabling molecular dispersion of Astaxanthin oleoresin 200g of same is added 200g sunflower oil and charged to SCF-CO2 high pressure vessel adding the mixing balls to the same. The vessel pressure and temperature are maintained at 160 Bar and 60 degree celsius.
- Example 10 In the SCF-CO2 vessel 200g Astaxanthin oleoresin 20.1% and 200g olive oil are charged. To stabilize 2g mixed tocopherol is also added. The pressure and temperature are maintained at 160 bar and 50 degree celsius. The SCF-CO2 passed 500 Kgs and the content of Astaxanthin is 11.25%. The lipid matrix shows good dispersibility indicating the role of olive oil and SCF-CO2 enabling the molecular dispersion.
- Example 11 The 1.0 refined SCF-CO2 extract of marigold is filled in the Liquid-liquid extractor and added 1.00 Kgs sunflower oil and homogenized at a pressure of 80-100 degree celsius.
- Image B1 Initial molecular dispersion of Image B2: Final liquid dispersion/ solution carotenoids of Carotenoids in olive oil 1:1 of marigold d
- the Microscopic pictures of marigold lutein ester after adding 1:1 volume of different oil and SCF-CO2 particle formation for enabling sub-micron particles and finally with stabilizers is illustrated in fig 1(a) to 1(j).
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Botany (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Pharmacology & Pharmacy (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Birds (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
L'invention décrit une dispersion moléculaire ou une solution vraie de substances bioactives lipophiles dans une matrice d'huile en concentration élevée telle que 20 % qui est rendue possible par l'application de dioxyde de carbone fluide supercritique. L'invention concerne en outre un procédé par lequel la dispersion moléculaire est stabilisée, de telle sorte que lors de l'ingestion, la dispersion moléculaire forme instantanément une Nano-émulsion dans l'estomac sans permettre la cristallisation de l'agent bioactif lipophile.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN202211056819 | 2022-10-03 | ||
IN202211056819 | 2022-10-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2024075134A1 true WO2024075134A1 (fr) | 2024-04-11 |
Family
ID=90607694
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IN2023/050899 WO2024075134A1 (fr) | 2022-10-03 | 2023-09-30 | Dispersion moléculaire supercritique (solution vraie) de bioactif lipophile dans une matrice lipidique et procédé correspondant |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2024075134A1 (fr) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3895695A1 (fr) * | 2020-04-15 | 2021-10-20 | Universidad Autónoma de Madrid | Méthodologie à base de dioxyde de carbone supercritique pour formuler des préparations bioactives |
BG113327A (bg) * | 2021-02-20 | 2022-08-31 | Екомаат Оод | Метод за получаване на биологично активни продукти от маслодайни рози rosa damascena mill. и rosa alba |
-
2023
- 2023-09-30 WO PCT/IN2023/050899 patent/WO2024075134A1/fr unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3895695A1 (fr) * | 2020-04-15 | 2021-10-20 | Universidad Autónoma de Madrid | Méthodologie à base de dioxyde de carbone supercritique pour formuler des préparations bioactives |
BG113327A (bg) * | 2021-02-20 | 2022-08-31 | Екомаат Оод | Метод за получаване на биологично активни продукти от маслодайни рози rosa damascena mill. и rosa alba |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Katouzian et al. | Formulation and application of a new generation of lipid nano-carriers for the food bioactive ingredients | |
Choi et al. | Nanoemulsions as delivery systems for lipophilic nutraceuticals: Strategies for improving their formulation, stability, functionality and bioavailability | |
Naseema et al. | A critical review of synthesis procedures, applications and future potential of nanoemulsions | |
Ganesan et al. | Lipid nanoparticles: Different preparation techniques, characterization, hurdles, and strategies for the production of solid lipid nanoparticles and nanostructured lipid carriers for oral drug delivery | |
Avachat et al. | Self nanoemulsifying drug delivery system of stabilized ellagic acid–phospholipid complex with improved dissolution and permeability | |
Dima et al. | Encapsulation of functional lipophilic food and drug biocomponents | |
Shehzad et al. | Improving the oxidative stability of fish oil nanoemulsions by co-encapsulation with curcumin and resveratrol | |
Yoo et al. | Novel self-nanoemulsifying drug delivery system for enhanced solubility and dissolution of lutein | |
Thuy et al. | Nanostructured lipid carriers and their potential applications for versatile drug delivery via oral administration | |
ES2396946T3 (es) | Emulsiones que comprenden un derivado de PEG de tocoferol | |
JP2020502040A (ja) | 植物源からカンナビノイドを選択的に抽出する方法 | |
Jain et al. | Formation and functional attributes of electrostatic complexes involving casein and anionic polysaccharides: An approach to enhance oral absorption of lycopene in rats in vivo | |
Mahfoudhi et al. | Nanoemulsions as potential delivery systems for bioactive compounds in food systems: Preparation, characterization, and applications in food industry | |
Jalali-Jivan et al. | Microemulsions as nano-reactors for the solubilization, separation, purification and encapsulation of bioactive compounds | |
Mahapatra et al. | Self-emulsifying drug delivery systems (SEDDS): An update from formulation development to therapeutic strategies | |
WO2008101344A1 (fr) | Compositions de composés lipophiles bioactifs solubles | |
Tang et al. | Solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) as food-grade nanovehicles for hydrophobic nutraceuticals or bioactives | |
EP4076487A1 (fr) | Formulations émulsifiantes de cannabinoïdes et/ou d'extraits de cannabinoïdes | |
Wu et al. | Liquid antisolvent precipitation: An effective method for ocular targeting of lutein esters | |
Dhritlahre et al. | Self-emulsifying formulations to augment therapeutic efficacy of nutraceuticals: From concepts to clinic | |
Singh et al. | Self-emulsifying drug delivery system (SEDDS): An emerging dosage form to improve the bioavailability of poorly absorbed drugs | |
Hsieh et al. | A fast and facile platform for fabricating phase-change materials-based drug carriers powered by chemical Marangoni effect | |
AU2018251624B2 (en) | Cold-water-dispersible chemical delivery system | |
CA3128653A1 (fr) | Compositions de nanoemulsion comprenant des saponines pour accroitre la biodisponibilite | |
WO2024075134A1 (fr) | Dispersion moléculaire supercritique (solution vraie) de bioactif lipophile dans une matrice lipidique et procédé correspondant |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 23874447 Country of ref document: EP Kind code of ref document: A1 |